Ophthalmic Implant Insertion Apparatus With Alignment Guide

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for implanting therapeutic devices in the eye are less than ideal due to difficulties in placement, refill port accessibility, and alignment, particularly because the eye moves, making precise placement and removal challenging.

Innovation Solution

A device and method for inserting and removing implantable therapeutic devices, featuring a handle and distal placement portion with engagement structures to securely hold and align the device, allowing for oblique needle penetration and injection of therapeutic fluid into a reservoir chamber, enabling easier placement and refill without the need for pre-filled devices.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Volume of moving object

If the implantable device is made small to decrease interference with vision, then the device size is reduced, but the refill port becomes difficult to fill

Engineering Contradiction:
Improvedevice sizeVSAvoidrefill port accessibility
Core Design Contradiction:
Volume of moving objectVSEase of operation

Solution Approach 1:

The patent introduces an insertion apparatus as an intermediary tool that facilitates filling the refill port of small implantable devices. The apparatus includes a needle that can penetrate the refill port and deliver therapeutic fluid, solving the accessibility problem without increasing device size. The apparatus acts as a mediator between the operator and the difficult-to-access refill port.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If the eye moves during implantation, then the procedure becomes more challenging, but precise placement is required

Engineering Contradiction:
Improveplacement precisionVSAvoidplacement difficulty
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The insertion apparatus is designed to pre-align and pre-position the implantable device before actual implantation. The apparatus includes alignment features and a structured insertion path that guide the device to the precise target location in the eye, compensating for eye movement during the procedure. This preliminary alignment ensures accurate placement despite the moving target.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If therapeutic fluid is injected through the needle at an angle oblique to the longitudinal axis, then the needle can penetrate the implantable device barrier, but alignment precision is required

Engineering Contradiction:
Improveneedle penetrationVSAvoidalignment precision
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The insertion apparatus serves as an intermediary that provides the oblique angle capability while maintaining alignment precision. The apparatus includes a guide structure that defines the oblique angle path, allowing the needle to penetrate the barrier effectively while the apparatus itself ensures precise angular alignment. This separates the penetration function from the alignment function.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS10603209B2Insertion and removal methods and apparatus for therapeutic devices
Publication Date: 2020.03.31 FORSIGHT VISION4 INC
  • US10603209B2 patent drawing
  • US10603209B2 patent drawing
  • US10603209B2 patent drawing

AI summary

Described herein is an apparatus to insert an implantable therapeutic device into a patient. The apparatus includes a proximal handle and a distal placement portion coupled to the proximal handle and configured to hold the implantable therapeutic device. The distal placement portion includes a first side having a first engagement structure at a distal end of the first side, the first engagement structure configured to surround at least a first portion of a proximal end region of the implantable therapeutic device. The distal placement portion includes a second, opposite side having a second engagement structure at a distal end of the second side, the second engagement structure configured to surround at least a second, opposite portion of the proximal end region of the implantable therapeutic device.